<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20160131026279N5</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-06-25</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>The effect of rehabilitation and non-invasive vagus nerve stimulation on the treatment of vestibular migraine</public_title>
      <acronym></acronym>
      <scientific_title>Effects of non-invasive vagus nerve stimulation and vestibular rehabilitation on dizziness, and postural control in adults with vestibular migraine</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-06-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>28</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/70604</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Randomization method: Individual random assignment to four equal groups with block randomization method using blocks of size 4; Randomization and random sequential allocation: done with Random Allocation Software;.</study_design>
      <phase>N/A</phase>
      <hc_freetext>vestibular migraine.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Intervention group 1 (VR): receiving vestibular rehabilitation program (exercises including seven VOR exercises, eight static VSR exercises and five dynamic VSR exercises), every day, 4 weeks. Intervention 2: Intervention group: Intervention group 2 (nVNS): receiving non-invasive vagus nerve stimulation, each stimulation session for 30 minutes (frequency 1 Hz, duration 0.2 milliseconds and the intensity of stimulation is the strongest sensation that patients can tolerate without pain), three times a week, 12 sessions, 4 weeks. Intervention 3: Intervention group: Intervention group 3 (VR+nVNS): receiving vestibular rehabilitation exercises along with non-invasive  vagus nerve stimulation, 4 weeks. Intervention 4: Intervention group: Intervention group 4 (VR+sham nVNS): receiving vestibular rehabilitation exercises along with non-invasive vagus nerve stimulation as a sham, 4 weeks.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Reporting as a PhD dissertation and papers

When:
2025 and after

To whom:
All people

Conditions:
Dissertation: In accordance with Tehran University of Medical Sciences copyright Paper: In accordance with the journal's policies to access the published paper

Where to obtain:
Dissertation: The library of the School of Rehabilitation, TUMS Papers: Databases

How to obtain:
For the dissertation, studying in the library For papers depends on the journal's policy.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mansoureh Adel Ghahraman</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Enghelab Ave.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1148956111</zip>
        <telephone>+98 21 7753 4364</telephone>
        <email>madel@tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mansoureh Adel Ghahraman</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Enghelab Ave.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1148956111</zip>
        <telephone>+98 21 7753 4364</telephone>
        <email>madel@tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age range of 18-50 years,
people with vestibular migraine (diagnosed by a neurologist and based on ICDH-3 guidelines)
no change in preventive medications during the last 2 months and during the study,
no use of suppressive medications Compensating the vestibular system with the opinion of an expert doctor related to the thesis,
no history of other vestibular disorders, Meniere's disease, ear surgery, intracranial surgery, posterior circulation stroke, epilepsy, severe cardiovascular disease, severe carotid artery disease, Previous carotid artery surgery, or implanted electrical devices.
no visual and motor deficit,
no history of previous vestibular rehabilitation program,
sufficient visual acuity to see the target point in the vHIT test.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>50 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Use of drugs that suppress vestibular system compensation,
suffering from neck pain and limited range of motion of the neck,
alcohol and drug use, history of orthopedic problems in the last 6 months
obvious deformity of the lower limbs such as scoliosis and kyphosis based on the observation of a physiotherapist
history of rheumatic or metabolic diseases based on individual report.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G43</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Migraine</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Intervention group 1 (VR): receiving vestibular rehabilitation program (exercises including seven VOR exercises, eight static VSR exercises and five dynamic VSR exercises), every day, 4 weeks.</i_keyword>
      <i_keyword>Intervention group: Intervention group 2 (nVNS): receiving non-invasive vagus nerve stimulation, each stimulation session for 30 minutes (frequency 1 Hz, duration 0.2 milliseconds and the intensity of stimulation is the strongest sensation that patients can tolerate without pain), three times a week, 12 sessions, 4 weeks</i_keyword>
      <i_keyword>Intervention group: Intervention group 3 (VR+nVNS): receiving vestibular rehabilitation exercises along with non-invasive  vagus nerve stimulation, 4 weeks</i_keyword>
      <i_keyword>Intervention group: Intervention group 4 (VR+sham nVNS): receiving vestibular rehabilitation exercises along with non-invasive vagus nerve stimulation as a sham, 4 weeks</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Dizziness Handicap Inventory score. Timepoint: Before and after intervention. Method of measurement: Dizziness Handicap Inventory.</prim_outcome>
      <prim_outcome>The total score of the vertigo symptom scale. Timepoint: Before and after intervention. Method of measurement: the vertigo symptom scale.</prim_outcome>
      <prim_outcome>Frequency of vertigo/dizziness. Timepoint: Before and after intervention. Method of measurement: vertigo/Dizziness frequency form with numbering 0-6.</prim_outcome>
      <prim_outcome>Vestibulo-ocular reflex gain. Timepoint: Before and after intervention. Method of measurement: video head impulse test (vHIT).</prim_outcome>
      <prim_outcome>Frequencyof covert and overt saccades. Timepoint: Before and after intervention. Method of measurement: video head impulse test (vHIT).</prim_outcome>
      <prim_outcome>Displacement of center of pressure in both anterior-posterior and medial-lateral directions. Timepoint: Before and after intervention. Method of measurement: Static posturography on force-plate and calculation with formula.</prim_outcome>
      <prim_outcome>Velocity of displacement of center of pressure in both anterior-posterior and medial-lateral directions. Timepoint: Before and after intervention. Method of measurement: Static posturography on force-plate and calculation with formula.</prim_outcome>
      <prim_outcome>Overall average velocity. Timepoint: Before and after intervention. Method of measurement: Static posturography on force-plate and calculation with formula.</prim_outcome>
      <prim_outcome>The area of displacement of the center of pressure. Timepoint: Before and after intervention. Method of measurement: Static posturography on force-plate and calculation with formula.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-02-01</approval_date>
        <contact_name>Ethics committee of School of Nursing and Midwifery &amp; Rehabilitation - Tehran University of Medical </contact_name>
        <contact_address>Enghelab Ave. Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
